Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls
dc.contributor.author | Tandon, Rajiv | en_US |
dc.contributor.author | Greden, John F. | en_US |
dc.contributor.author | Haskett, Roger F. | en_US |
dc.date.accessioned | 2006-04-10T15:50:42Z | |
dc.date.available | 2006-04-10T15:50:42Z | |
dc.date.issued | 1993-03 | en_US |
dc.identifier.citation | Tandon, Rajiv, Greden, John F., Haskett, Roger F. (1993/03)."Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls." Schizophrenia Research 9(1): 19-23. <http://hdl.handle.net/2027.42/30911> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6TC2-45RCD5C-32/2/e457c7b9530500f629f212274c6c36bf | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/30911 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8461267&dopt=citation | en_US |
dc.description.abstract | Intravenous infusion of physostigmine (a centrally active anticholinesterase agent) in normal subjects leads to a syndrome of psychomotor inhibition; this has been proposed as a model for selected symptoms of depression. In view of its similarity to the negative schizophrenic syndrome, we compared the `physostigmine syndrome' to the negative symptom profile by evaluating the behavioral effects of intravenous physostigmine infusion in seven normal volunteers. Observer ratings and self description revealed significant withdrawal, apathy, alogia, lethargy, decreased energy, slowed thoughts, diminished affective responsivity, and reduced hedonic capacity. Subjects did not report sadness, ideas of hopelessness, worthlessness, or guilt. These findings support the implication of cholinergic hyperactivity as one mechanism in the pathophysiology of negative schizophrenic symptoms. | en_US |
dc.format.extent | 501377 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychology | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Social Sciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Michigan Medical Center, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Michigan Medical Center, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Michigan Medical Center, Ann Arbor, MI 48109, USA | en_US |
dc.identifier.pmid | 8461267 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/30911/1/0000580.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0920-9964(93)90004-3 | en_US |
dc.identifier.source | Schizophrenia Research | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.